A ntibiotic resistance is a fact of life that we must accept and confront. Consequently, modern pharmaceutical companies have faced repeated crises when new forms of antibiotic resistance emerged in previously susceptible pathogens. In each of these crises, the industry has rallied to bring forward new therapeutic approaches. During the past 30 years, I have been directly involved in several of...

Considering the importance of decision- making in investment, this study prioritizes the accepted pharmaceutical companies in Tehran stock exchange, during 2013-2017 using the following criteria: the return on investment (ROI), reminded increment (RI), return on sales (ROS) and the earnings per share (EPS). Price per earnings ratio of each share (P/E), return on equity (ROE), return on assets (...

Several recent newspaper exposés have revealed previously unreported fi nancial relationships between prominent physician researchers and various pharmaceutical companies. Such stories raise serious questions about the objectivity of such research and whether improved eff ectiveness and safety of pharmaceutical agents is as important as commercial profi t to the pharmaceutical industry or the d...

PROBLEM A multinational company with operations in several African countries was committed to offer antiretroviral treatment to its employees and their dependants. APPROACH The Accelerating Access Initiative (AAI), an initiative of six pharmaceutical companies and five United Nations' agencies, offered the possibility of obtaining brand antiretroviral drugs (ARVs) at 10% of the commercial pri...

www.pharmaporta l .com ackaging is one of the largest industry sectors in the world, worth $280 billion. Consumer healthcare packaging represents 4% ($11.2 billion) of the packaging industry. As drug manufacturers approach the 21st century, they face a number of challenges that packaging can help them meet. A decade ago packaging often was an afterthought for many pharmaceutical companies, view...

In this article we propose a new approach to pricing for patent-protected (on-patent) pharmaceuticals. We describe and define limit pricing as a method for drug companies to maximize revenue for their investment by offering budget-neutral pricing to encourage early adoption by payers. Under this approach, payers are incentivized to adopt innovative but expensive drugs more quickly if drug compa...

China's Good Manufacturing Practice (GMP) standards that mainly parallel WHO standards were made compulsory in 2004. However, GMP implementation had both positive as well as negative impacts on the pharmaceutical industry, with negatives including pharmaceutical companies suffering economic hardships, poor execution of GMP standards, and sequent health scares. This report briefly describes the ...

The pharmaceutical industry is in the midst of a fundamental transformation. Institutional regulations that have been in place for decades are being removed and competitive pressures force pharmaceutical companies to adopt customer oriented strategies. Information technology which has traditionally been applied to many processes in this industry is an important enabler for the interaction with ...

The pharmaceutical industry is in the midst of a fundamental transformation. Institutional regulations that have been in place for decades are being removed and competitive pressures force pharmaceutical companies to adopt customer-oriented strategies. Information technology which has traditionally been applied to many processes in this industry is an important enabler for the interaction with ...

BACKGROUND Little is known about patients' awareness of and attitudes about gifts to physicians from pharmaceutical companies. METHODS During a 7-week period in summer 1994, we surveyed adults (18 years of age and older) in the waiting rooms of two family practice centers in central Missouri. Four-hundred eighty-six adults (83 percent participation rate) responded to a self-administered quest...